BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16738205)

  • 1. Matrix metalloproteases in aberrant fibrotic tissue remodeling.
    Pardo A; Selman M
    Proc Am Thorac Soc; 2006 Jun; 3(4):383-8. PubMed ID: 16738205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and lung injury.
    Pardo A; Selman M
    Braz J Med Biol Res; 1996 Sep; 29(9):1109-15. PubMed ID: 9181053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
    Ries C; Petrides PE
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of matrix metaloproteases in idiopathic pulmonary fibrosis.
    Pardo A; Selman M
    Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S9. PubMed ID: 23259796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis.
    Pardo A; Cabrera S; Maldonado M; Selman M
    Respir Res; 2016 Mar; 17():23. PubMed ID: 26944412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis.
    Fukuda Y; Ferrans VJ; Schoenberger CI; Rennard SI; Crystal RG
    Am J Pathol; 1985 Mar; 118(3):452-75. PubMed ID: 3883797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric lung disease: from proteinases to pulmonary fibrosis.
    Chua F; Sly PD; Laurent GJ
    Pediatr Pulmonol; 2005 May; 39(5):392-401. PubMed ID: 15786437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their expression in mammary gland.
    Uria JA; Werb Z
    Cell Res; 1998 Sep; 8(3):187-94. PubMed ID: 9791732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of matrix metalloproteinase activity in cancer.
    Jones JL; Walker RA
    J Pathol; 1997 Dec; 183(4):377-9. PubMed ID: 9496252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
    Damjanovski S; Amano T; Li Q; Pei D; Shi YB
    Dev Dyn; 2001 May; 221(1):37-47. PubMed ID: 11357192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma.
    Royce SG; Tan L; Koek AA; Tang ML
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):238-46. PubMed ID: 19354071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis.
    Hayashi T; Rush WL; Travis WD; Liotta LA; Stetler-Stevenson WG; Ferrans VJ
    Arch Pathol Lab Med; 1997 Sep; 121(9):930-7. PubMed ID: 9302924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.
    Chua F; Laurent GJ
    Proc Am Thorac Soc; 2006 Jul; 3(5):424-7. PubMed ID: 16799086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent.
    Fritz DK; Kerr C; Fattouh R; Llop-Guevara A; Khan WI; Jordana M; Richards CD
    J Immunol; 2011 Jan; 186(2):1107-18. PubMed ID: 21160052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation mechanisms of matrix metalloproteinases.
    Nagase H
    Biol Chem; 1997; 378(3-4):151-60. PubMed ID: 9165065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.